Continuous intravenous deferoxamine infusion. Treatment of secondary hemochromatosis in adults

JAMA. 1978 May 19;239(20):2149-51.

Abstract

Adult patients with chronic iron overload were given oral ascorbic acid and continuous intravenous infusions of deferoxamine mesylate. The dosage of deferoxamine mesylate was altered every 48 hours from 1 g/sq m/24 hr to 2 or 4 g/sq m/24 hr. The average iron mobilization was 55.6 mg per day at the 1 g/sq m/24 hr dosage level, 78.6 mg every 24 hours at the 2 g/sq m/24 hr dosage level, and 90.1 mg every 24 hours at the 4 g/sq m/24 hr dosage level. Iron mobilization was undiminished when successive 14-day courses of deferoxamine separated by six-week intervals were administered.

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Ascorbic Acid / administration & dosage
  • Ascorbic Acid / therapeutic use
  • Deferoxamine / administration & dosage*
  • Female
  • Hemochromatosis / drug therapy*
  • Humans
  • Infusions, Parenteral
  • Iron / urine
  • Male
  • Middle Aged
  • Time Factors

Substances

  • Iron
  • Deferoxamine
  • Ascorbic Acid